Key Findings
The North America sepsis diagnostics market is anticipated to register a 7.87% CAGR, over the studied period, 2021-2028. The market growth of the region is attributed to factors like, the high adoption rate of sepsis diagnostic instruments in laboratories and diagnostic facilities, the favorable medical reimbursement scenario, the surging incidence of sepsis, and the well-established healthcare infrastructure.

Market Insights
The North America sepsis diagnostics market growth is determined by evaluating Canada and the United States. Canada’s expenditure on healthcare is fairly significant. For instance, according to the 2018 report by the Organization for Economic Co-operation and Development (OECD), a total of 11.5% of the country’s gross domestic product (GDP), equating to nearly $242 billion, was spent on healthcare. As per the Canadian Sepsis Foundation, at least 1 in 18 fatalities in Canada are associated with sepsis, and the medical condition is the twelfth leading cause of death across the nation. Moreover, Canada spends approximately CAD 325 million, annually, on the treatment of the disease.
Canada harbors a broad interest in developing protocols as well as identifying the ideal technologies for diagnosing sepsis, especially in remote and rural regions. The country’s CIHR Sepsis Research Network Initiative is co-led by the Institute of Infection and Immunity (III) and the Institute of Circulatory and Respiratory Health (ICRH), in association with the Institute of Population and Public Health (IPPH), the Institute of Nutrition, Metabolism, and Diabetes (INMD), and Mitacs. As a result, these factors are projected to drive the sepsis diagnostics market in Canada, over the forecasted years.

Competitive Insights
Key players operating in the market are, Abbott Laboratories, Bruker Corporation, Becton, Dickinson and Company, Luminex Corporation, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments